CTM Curated Research

Healing the gut ecosystem: Traditional Chinese medicine and the microbiome–immune axis

Traditional Chinese Medicine (TCM) offers a holistic, multi-target approach to gastrointestinal health and modulation of the gut microbiota. Grounded in thousands of years of clinical practice, TCM formulations have demonstrated an ability to restore intestinal barrier function, regulate immune responses, and rebalance microbial communities across a broad spectrum of conditions, from sepsis-related gastrointestinal dysfunction to ulcerative colitis and metabolic syndrome.

Within the integrative approaches to complex health conditions, it becomes increasingly foundational to examine the body as an interconnected whole. TCM exemplifies the need for a multimodal approach to gastrointestinal disorders, recognizing gut health as inseparable from immune function, inflammation, and overall metabolic balance. A growing body of research is bridging millennia of empirical knowledge with contemporary science, confirming that the gut microbiome is a central driver of health and disease, and that TCM herbal formulations are uniquely positioned to restore microbial equilibrium across multiple biological pathways at once. Diverging from a fundamentally different paradigm from single-target pharmaceutical approaches provides some hope for complex conditions that conventional treatments fall short of treating.

To support these, five compelling recent studies illustrate how TCM effectively modulates the gut microbiota to address serious gastrointestinal and systemic conditions:

The first study provides a network meta-analysis that examines TCM interventions for sepsis-associated gastrointestinal dysfunction. Across 74 randomized controlled studies, researchers found that specific TCM formulations significantly outperformed conventional therapy alone. Each of these compounds work through distinct gut microbiota-mediated mechanisms. Dachaihu Tang was the most effective at improving gastrointestinal dysfunction, with the highest likelihood (92.7%) of reducing digestive complications. Active compounds (saikosaponin A/B and baicalin) helped improve gut motility. Rhein is another ingredient that helps reduce inflammation in the body. It works by blocking the proteins (VCAM-1 and ICAM-1), responsible for making inflammation worse and limiting blood flow. By stopping these proteins, inflammation is reduced and blood circulation improves.

The second study provides a systematic review and network meta-analysis of TCM’s role in cancer immunotherapy via gut microbiota modulation. TCM compounds such as ginseng polysaccharides, astragalus polysaccharides, and other herbal formulas were shown by research to reshape tumor immune microenvironment. This mechanism was achieved by enriching beneficial bacteria (Akkermansia muciniphila and Lactobacillus species), thus increasing short-chain fatty acid production and reducing immunosuppressive metabolites. This offers a novel pathway for strengthening the clinical effectiveness of immune checkpoint inhibitors in cancer care.

The third article examines TCM’s treatment of Helicobacter pylori to prevent infection amongst military populations. Results demonstrate how TCM formulations exhibit direct antimicrobial effects against H.pylori, as well as modulate gut microbiota composition to prevent infection recurrence and reduce antibiotic resistance.  This is a critical advantage given the increasing failure rates of conventional triple therapy regimens.

The fourth study investigates how ulcerative colitis creates a damaging cycle between the immune system and gut microbiome, and how TCM strategies interrupt this pathological cycle. In ulcerative colitis, the immune system overreacts, releasing damaging structures known as neutrophil extracellular traps (NETs). Simultaneously, the gut microbiome enters a state of dysbiosis, with harmful bacteria overtaking beneficial ones. Researchers found that formulas like Baitouweng Decoction and Houpo Heji concurrently inhibit excessive NET formation, while restoring beneficial microbial populations and increasing anti-inflammatory metabolites, such as short-chain fatty acids. Through these mechanisms, both immune dysregulation and dysbiosis are effectively addressed within a single therapeutic framework.

The fifth study presents a comprehensive review of TCM’s molecular mechanisms for treating metabolic syndrome via modulation of the gut microbiota. Metabolic syndrome is a cluster of related conditions that often co-occur and raise the risk of heart disease, stroke, and type 2 diabetes. These include high blood sugar, excess abdominal adipose tissue, and abnormal cholesterol levels. The research demonstrates that TCM polyphenols (natural chemical compounds found in plants with anti-inflammatory properties) and herbal compounds regulate the production of key microbial metabolites (substances produced by gut bacteria as they break down food and other substances), including short-chain fatty acids (breakdown of fiber), bile acids (produced by the liver to digest fats), and trimethylamine-N-oxide (produced when gut bacteria break down certain foods, like meat and eggs). These metabolites impact glucose metabolism, lipid profiles, insulin sensitivity, and inflammation, helping to regulate blood sugar, reduce inflammation, and improve cholesterol and insulin function across multiple organ systems.

Tags: Gastrointestinal health, Gut microbiota modulation, Herbal medicine, Inflammatory bowel disease, Integrative medicine, Metabolic syndrome, Microbiome-immune axis, Traditional Chinese Medicine (TCM)

Research Glossary

Research has its own vocabulary. To help you decipher research, we created a Glossary to ease the way.
You may access it here: Research Glossary

Referenced Research Publications

World journal of gastroenterology
2025, May 14

Potential of traditional Chinese medicine in managing and preventing Helicobacter pylori infection in Chinese military

Abstract

Helicobacter pylori (H. pylori) infection is prevalent among Chinese military personnel, with regional rates exceeding 40%, and is a well-established risk factor for gastric cancer. Addressing this infection is vital for improving soldiers’ health and operational readiness while reducing the long-term healthcare burden. This commentary explores the feasibility and advantages of incorporating traditional Chinese medicine (TCM) into strategies for managing and preventing H. pylori infections within the military. TCM offers a multi-target mechanism that not only combats bacterial infections but also enhances gastrointestinal health and boosts immunity, making it particularly effective in high-stress environments like the military. Unlike antibiotics, TCM is less likely to induce resistance even with large-scale use, providing a sustainable treatment option. Its affordability and cultural acceptance among Chinese personnel further enhance its feasibility. Additionally, TCM’s history in military medicine supports its credibility, and its flexibility allows for personalized treatment tailored to individual soldiers’ needs. TCM’s convenient storage and deployment make it ideal for remote and challenging environments. Integrating TCM into military healthcare systems could provide a holistic, cost-effective, and sustainable approach to managing H. pylori infections, reducing prevalence and associated risks such as gastric cancer. Future research and pilot programs are essential to validate TCM’s effectiveness and implementation in military settings.

Reference

Liu, H., Gu, R. J., Li, C., Wang, J. X., & Dong, C. S. (2025). Potential of traditional Chinese medicine in managing and preventing Helicobacter pylori infection in Chinese military. World journal of gastroenterology, 31(18), 103754. https://doi.org/10.3748/wjg.v31.i18.103754

Frontiers in cellular and infection microbiology
2025, October 15

Crosstalk between neutrophil extracellular traps and gut microbiota in ulcerative colitis: traditional Chinese medicine strategies

Abstract

Ulcerative colitis (UC), a chronic and complex inflammatory bowel disorder, presents ongoing therapeutic challenges. Although multi-tiered anti-inflammatory strategies represent significant advances, issues like treatment resistance and adverse effects persist. Consequently, identifying more effective therapeutic targets and potentially curative strategies remains imperative. Emerging evidence underscores neutrophils, particularly through neutrophil extracellular trap (NET) formation, as pivotal contributors to UC pathogenesis. In affected individuals, excessive NET accumulation exacerbates intestinal inflammation, compromises the epithelial barrier, activates coagulation pathways, promotes resistance to biologic therapies, and may even facilitate malignant transformation. Critically, a bidirectional interplay exists between NETs and the gut microbiota (GM) in this disease. Recent research indicates that certain traditional Chinese medicine (TCM) herbal extracts and formulas hold promise for modulating aberrant NET generation and GM composition. This review examines the roles of NETs and GM in UC pathogenesis and synthesizes evidence on potential TCM-based interventions targeting these pathways, offering novel perspectives for future therapeutic development.

Reference

Feng, Y., Liu, Y., Qiu, X., Jiang, J., Mo, J., & Xv, Y. (2025). Crosstalk between neutrophil extracellular traps and gut microbiota in ulcerative colitis: traditional Chinese medicine strategies. Frontiers in cellular and infection microbiology, 15, 1692312. https://doi.org/10.3389/fcimb.2025.1692312

World journal of gastroenterology
2025, May 28

Potential of traditional Chinese medicine in gastrointestinal disorders: Hericium erinaceus in chronic atrophic gastritis

Abstract

Traditional Chinese medicine (TCM) has been extensively explored with various naturally derived compounds as a potential therapeutic agent for chronic atrophic gastritis (CAG). In addition to the aspects discussed in the reviewed article, this invited commentary explores the initial available evidence on a fungus from TCM, Hericium erinaceus, in the context of CAG. Initial clinical data suggest the potential of this fungus in inducing clinical and histological improvements in patients with CAG, as well as a marked antimicrobial activity against Helicobacter pylori infection. Preclinical cellular evidence also indicates an antineoplastic role in gastric carcinogenesis, mediated by two components: Erinacine A and S. Further evidence is needed to propose this fungus as a potential complementary therapeutic approach for CAG.

Reference

Pellegrino, R., & Gravina, A. G. (2025). Potential of traditional Chinese medicine in gastrointestinal disorders: Hericium erinaceus in chronic atrophic gastritis. World journal of gastroenterology, 31(20), 106615. https://doi.org/10.3748/wjg.v31.i20.106615

Molecular biomedicine
2025, August 26

Metabolic syndrome: molecular mechanisms and therapeutic interventions

Abstract

Metabolic syndrome (MetS, MS) is a group of metabolic disorders characterized by central obesity, insulin resistance, dyslipidemia, and imbalance of glucose homeostasis. Studies have revealed that the molecular mechanism of MetS may be related to adipose dysfunction, insulin resistance, chronic inflammation, oxidative stress, the gut microbiota and epigenetic modifications. At present, the clinical treatment of MetS is limited to lifestyle changes and targeted drugs for a single risk factor, which makes it difficult to achieve the desired effects. Recent studies have shown that the gut microbiota and its metabolites play important roles in various metabolic activities. Polyphenols are the most prevalent chemical components in traditional Chinese medicines (TCMs). TCMs have long been used in the treatment of MetS. TCM polyphenols exhibit significant efficacy in the treatment of MetS by regulating the homeostasis of the gut microbiota, affecting the secretion of its metabolites, and regulating related upstream and downstream pathways such as the AMPK, PPAR, MAPK, PI3K/Akt and NF-κB pathways. This study investigated the molecular mechanisms of MetS and gut microbiota homeostasis in relation to the therapeutic efficacy of TCM polyphenols against MetS. This study further compared TCM polyphenols with existing treatments, thus providing a novel theoretical basis and strategy for MetS treatment and prevention using TCM polyphenols.

Reference

Zheng, L., Zeng, A., Liu, L., Tian, W., Wang, R., Zhang, L., Hua, H., & Zhao, J. (2025). Metabolic syndrome: molecular mechanisms and therapeutic interventions. Molecular biomedicine, 6(1), 59. https://doi.org/10.1186/s43556-025-00303-5

Pharmacological research
2025, December 22

Applications of traditional Chinese medicine in cancer immunotherapy via gut microbiota modulation: Current status, mechanisms, challenges and perspectives

Abstract

Cancer immunotherapy faces significant limitations due to therapeutic resistance. Emerging evidences have identified the gut microbiota (GM) as a crucial regulator of antitumor immunity through its effects on the tumor immune microenvironment (TIME). Guided by the principle of “fu zheng qu xie” (fortifying healthy qi to reinforce immune homeostasis and eliminating pathogenic factors to promote immune clearance), traditional Chinese medicine (TCM) exerts multi-target systemic regulation. Specifically, TCM modulates gut microecology, which in turn regulates the production of microbial metabolites (e.g., short-chain fatty acids, bile acids), ultimately reprogramming TIME by enhancing immune cell infiltration into the tumor parenchyma, optimizing T-cell cytotoxicity and differentiation, improving antigen presentation, and alleviating immunosuppression. This review systematically summarizes the causal chain of “TCMGMmetabolitesimmune cellsTIME” across different immune phenotypes, emphasizing how bioactive TCM components and classical formulas reshape microbial communities, enrich beneficial bacteria, and regulate metabolic pathways to potentiate cancer immunotherapy. Despite promising preclinical data, challenges persist due to mechanistic complexity, the lack of standardization, and limited clinical translation. Potential solutions include multi-omics integration, intelligent screening of herbal compounds, and targeted delivery systems. With advancing pharmacological insights, TCM-derived microbiome modulators (TMMs), defined as phytochemicals and formulations that systematically modulate gut microecology, may overcome immunotherapy resistance, representing a novel strategy for enhancing cancer immunotherapy.

Reference

Tao, H., Mao, K., Zhang, Z., Wei, W., Huang, X., Chen, Y., Mei, S., & Tian, X. (2025). Applications of traditional Chinese medicine in cancer immunotherapy via gut microbiota modulation: Current status, mechanisms, challenges and perspectives. Pharmacological research, 222, 108020. https://doi.org/10.1016/j.phrs.2025.108020